IPPOLITO, EDY
 Distribuzione geografica
Continente #
AS - Asia 5.550
EU - Europa 438
NA - Nord America 379
AF - Africa 8
SA - Sud America 5
OC - Oceania 4
Totale 6.384
Nazione #
SG - Singapore 5.214
US - Stati Uniti d'America 356
CN - Cina 166
IT - Italia 142
HK - Hong Kong 127
DE - Germania 78
GB - Regno Unito 60
NL - Olanda 47
EE - Estonia 33
FI - Finlandia 28
CA - Canada 19
CZ - Repubblica Ceca 10
IN - India 10
UA - Ucraina 10
ID - Indonesia 9
TR - Turchia 8
RO - Romania 7
ZA - Sudafrica 7
AT - Austria 6
FR - Francia 6
BD - Bangladesh 5
AU - Australia 4
MX - Messico 4
BR - Brasile 3
ES - Italia 3
JP - Giappone 3
PL - Polonia 3
SE - Svezia 3
TW - Taiwan 2
AR - Argentina 1
CL - Cile 1
IL - Israele 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
OM - Oman 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 6.384
Città #
Singapore 192
Hong Kong 123
Ashburn 94
Hefei 91
Rome 68
Munich 62
Boardman 58
Shanghai 56
London 53
Amsterdam 40
Los Angeles 20
Milan 16
Helsinki 14
Turku 14
Toronto 12
Washington 11
Council Bluffs 10
Brno 8
San Francisco 8
West Jordan 8
Pune 6
Redmond 6
Santa Clara 6
Seattle 6
Sona 6
New York 5
Rocca di Papa 5
Ankara 4
Chicago 4
Mexico City 4
Vicenza 4
Bologna 3
Boston 3
Brooklyn 3
Capaccio 3
Montesilvano Marina 3
Naples 3
Stockholm 3
São Paulo 3
Vienna 3
Warsaw 3
Bangalore 2
Banqiao 2
Bucharest 2
Central 2
Guangzhou 2
Hanover 2
Harbin 2
Jakarta 2
Lyon 2
Nuremberg 2
Olomouc 2
Palermo 2
Pescara 2
Sant'Anastasia 2
Southall 2
Sydney 2
Temecula 2
Tokyo 2
Vancouver 2
Xi'an 2
Andover 1
Atlanta 1
Beijing 1
Bismarck 1
Bratislava 1
Buffalo 1
Calgary 1
Cameri 1
Canberra 1
Centurion 1
Charlotte 1
Chengdu 1
Chennai 1
Cleveland 1
Clifton 1
Concord 1
Dallas 1
Denver 1
Dezhou 1
Dhaka 1
Edison 1
Frankfurt am Main 1
Freetown 1
Greenville 1
Haikou 1
Handan 1
Harrisburg 1
Islamabad 1
Johannesburg 1
Jung-gu 1
Kowloon City 1
Liberty Lake 1
Marino 1
Markham 1
Melbourne 1
Muscat 1
New Delhi 1
Newark 1
Paris 1
Totale 1.123
Nome #
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 228
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 225
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 197
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 192
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 189
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 189
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 184
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 184
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 183
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 181
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer 180
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 179
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 178
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 175
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 175
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I–II study (ADA-RT-1) 174
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study 171
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 167
Lymph nodal radiotherapy in breast cancer: what are the unresolved issues? 165
Preventing Cardiotoxicity in Personalized Breast Irradiation 163
Variability in axillary lymph node delineation for breast cancer radiotherapy in presence of guidelines on a multi-institutional platform 162
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 115
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 102
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 100
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 95
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 92
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 90
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 90
Subaxillary Replacement Flap Compared with the Round Block Displacement Technique in Oncoplastic Breast Conserving Surgery: Functional Outcomes of a Feasible One Stage Reconstruction 90
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 88
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 87
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 87
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 86
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 85
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 83
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 82
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 82
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 81
Daily on-line set-up correction in 3D-conformal radiotherapy: Is it feasible? 77
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 63
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 60
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 60
The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study 56
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 55
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study 54
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 47
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 42
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 28
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 26
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 22
PATTERN OF FAILURE AFTER ADAPTIVE RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC). 21
Induction chemotherapy with cisplatin, 5-fluorouracil, and cetuximab followed by radiotherapy and cetuximad in head and neck cancers: Preliminary results of a modern integrated approach 18
Radiotherapy in breast cancer with voluntary deep- inspiration breath-hold using BrainLab Exactrac 18
PO-0672 Ten years experience of breast reconstruction after mastectomy in previously irradiated patients 18
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 18
Somatostatin analogs and disease control in castration-resistant prostate cancer: different biological behavior? Case series and review of the literature 18
PV-0276 Adaptive radiotherapy: rate of "marginal" failure after "replanning" in combined treatment of NSCLC. 17
SBRT: A viable option for treating adrenal gland metastases 17
Whole-Breast Irradiation: A Subgroup Analysis of Criteria to Stratify for Prone Position Treatment 17
OA24.02 - Locally Advanced Non-Small Cell Lung Cancer: RadioTherapy with Adaptive Strategy (LARTIA Trial) 16
Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study † 15
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 15
The role of mammography after breast-conserving surgery and adjuvant chemotherapy 15
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 14
Erlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical results. 14
Stereotactic body radiation therapy for early stage NSCLC: clinical outcomes 14
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study 14
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 13
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 13
Precision radiotherapy by SPECT lung functional imaging in NSCLC 13
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/ RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups 12
Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups 11
Occult mediastinal node involvement in non-small cell lung cancer after negative uptake on PET/CT: Ripples through staging and therapy. Case report and critical review 11
IGRT in rectal cancer 11
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 11
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion preliminary report on toxicity 10
Predictive factors of late-onset rectal mucosal changes after radiotherapy of prostate cancer 10
Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group 10
Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial 9
Postoperative Intensity Modulated Radiation Therapy in High Risk Prostate Cancer: A Dosimetric Comparison 9
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: A case series 9
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 9
Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1) 9
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 8
External Beam Radiotherapy Plus 24-Hour Continuous Infusion of Gemcitabine in Unresectable Pancreatic Carcinoma: Long-Term Results of a Phase II Study 8
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 8
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: A phase I study 8
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 8
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 7
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 6
Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): a cooperation among AIRO Gyn, MITO and MaNGO groups 4
Totale 6.472
Categoria #
all - tutte 25.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202284 0 0 2 4 3 2 1 3 10 3 0 56
2022/202341 0 1 0 2 1 1 4 13 3 0 12 4
2023/2024231 8 19 15 11 17 82 13 11 3 17 10 25
2024/20256.064 41 20 121 63 38 103 78 27 227 384 2.316 2.646
2025/202652 52 0 0 0 0 0 0 0 0 0 0 0
Totale 6.472